Trade Summary

6 days ago, Coastlands Capital LP, serving as 10% owner Owner at ADIAL PHARMACEUTICALS, INC. (ADIL), purchased 11,753 shares at $2.78 per share, for a total transaction value of $32,637.87. Following this transaction, Coastlands Capital LP now holds 385,075 shares of ADIL.

This purchase represents a 3.15% increase in Coastlands Capital LP's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, July 9, 2026 and publicly disclosed via SEC Form 4 filing on Monday, July 13, 2026 at 10:30 AM ET, 4 days after the trade was made.

ADIAL PHARMACEUTICALS, INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.